The CG-100 study is evaluating a new investigational treatment that may reduce the rate of diverting stoma and its related complications.
- Adults between 22 and 65 years of age.
- Those who are undergoing colorectal surgery with a mesorectal excision and are planned to have a protecting diverting stoma as part of the operation.
- Additional criteria apply
Those who qualify will receive treatment from a board-certified surgeon.
All information provided is confidential and will not be given or sold to any other agency without prior consent.